US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
CN

CNMDStockCONMED Corp

New York Stock Exchange · Healthcare

$44.42 last close 2026-10-09
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment CNMD's does — no target price to set, unlike "Alert" above.

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-28
0 of 7 pass our own screen — all 7 agree here
Purification 100.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 30.4% aligned
VWAPPrice below VWAP ($45.23)
VolumeRelative volume 3.8× the 20-day average
Momentum10-day rate of change -2.1%

CONMED Corp (CNMD) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

449 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Price target
$45.50
+2.4% · 6 analysts
Institutional own.
116.7% *
of shares
Momentum (10d)
-2.1%
rate of change
SMC grade
F · 28
30.4% aligned
100.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-06-30)
F · 28
SMC grade — 30.4% timeframe alignment
-2.1%
Rate of change (10d)
$45.50
Price target (+2.4%) · 6 analysts
116.7%
Institutional ownership *

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-06-30. CNMD files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 61.32% 30.00% Fail
Interest-bearing investments 2.74% 30.00% Pass
Non-permissible income 0.00% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 36.27% 33.00% Fail
Interest-bearing investments 1.62% 33.00% Pass
Non-liquid assets 87.95% at least 20.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 36.27% 33.33% Fail
Cash + interest-bearing securities 1.62% 33.33% Pass
Accounts receivable 12.05% 33.33% Pass
Non-permissible income 0.00% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 36.27% 33.33% Fail
Cash + interest-bearing securities 1.62% 33.33% Pass
Accounts receivable 12.05% 50.00% Pass
Non-permissible income 0.00% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 54.06% 33.00% Fail
Cash + interest-bearing securities 2.42% 33.00% Pass
Accounts receivable 15.54% 33.00% Pass
Non-permissible income 0.00% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 44.75% 33.00% Fail
Cash + interest-bearing securities 2.00% 49.00% Pass
Accounts receivable 12.86% 49.00% Pass
Non-permissible income 0.00% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 44.75% 33.33% Fail
Cash + interest-bearing securities 2.00% 33.33% Pass
Accounts receivable 14.86% 49.00% Pass
Non-permissible income 0.00% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 5.0pts
AAOIFI Standard 21 (% of market cap)debt ratio 31.3pts
Dow Jones Islamic Market (% of 24-mo avg market cap)debt ratio 21.1pts
S&P Shariah Indices (% of 36-mo avg market cap)debt ratio 11.8pts

The numbers the ratios are built from

Read from CNMD's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $1.4B 2026-06-30 Revenues
Interest-bearing debtShort and long-term borrowings $834.2M 2026-06-30 LongTermDebtAndCapitalLeaseObligations, LongTermDebtAndCapitalLeaseObligationsCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $37.3M 2026-06-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $2.3B 2026-06-30 Assets
Market capDenominator for AAOIFI $1.4B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $1.9B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $1.6B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-06-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

What changed, and when

Verdict history for CNMD. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for CNMD has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

ℹ️ no compliance scan has run for 3 days - this is not a reading of today

51.8646.9241.9937.0532.112025-10-132026-04-142026-10-09

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
42.92
S2
43.48
S1
44.30
PIVOT
44.86
R1
45.68
R2
46.24
R3
47.06

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
42.29 – 49.91
±8.27% from 46.10, made 2026-09-29 · resolves 2026-10-06
SELL
from 19 indicators
61.9% of our last 5789 forecasts landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
4 buy · 0 neutral · 8 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.90NEUTRAL
Stochastic %K (14)10.51BUY
CCI (20)-119.77BUY
Williams %R (14)-89.49BUY
MACD (12,26,9)-0.12SELL
ROC (10)-2.12SELL
Momentum (10)-0.96SELL
EMA (10)45.39SELL
SMA (10)45.72SELL
EMA (20)45.96SELL
SMA (20)45.82SELL
EMA (30)46.23SELL
SMA (30)46.65SELL
EMA (50)45.89SELL
SMA (50)48.01SELL
EMA (100)44.15BUY
SMA (100)42.61BUY
EMA (200)43.01BUY
SMA (200)41.04BUY

About CONMED Corp

Healthcare · Medical Devices

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

conmed.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 42
⏰ 4H RANGING 33
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-2.1%
Rate of change (10d)
3.8×
Volume vs its 20-day average
-1.04
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-10-06 · Asset managers net 906615 (+2612)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.